Brazil should get antiviral tecovirimat to fight epidemic monkey flower (monkey flower) in the country. The announcement was made Monday (2) by health minister Marcelo Queiroga on his personal profile on Twitter.
The drug will be obtained through the Pan American Health Organization (PAHO). There is still no data to prove its effectiveness in fighting the disease, but the drug is used by European and American governments to control the disease.
Ministry of Health, through PAHO (@pahowho), the antiviral tecovirimat ???? to strengthen the fight against the Monkeypox epidemic in Brazil. More serious cases will be considered at first.
— Marcelo Queiroga ????????? (@mqueiroga2) August 1, 2022
According to the minister, priority will be given to patients with severe symptoms in drug delivery. There are already more than a thousand cases of the disease in the country. Last Friday (29), the first death from the disease was confirmed.
In Europe and the United States, tecovirimat is in compassionate use as a type of special authorization for unregistered drugs. The new drug acts against a specific protein of the orthopox virus that causes disease and can eliminate human, cow, and monkeypox pathogens in animal tests.
However, due to the low number of cases, the new drug cannot be tested on a large scale to prove its efficacy in humans. For this reason, tecovirimat is provisionally authorized for use worldwide.
Source: Tec Mundo
I am Bret Jackson, a professional journalist and author for Gadget Onus, where I specialize in writing about the gaming industry. With over 6 years of experience in my field, I have built up an extensive portfolio that ranges from reviews to interviews with top figures within the industry. My work has been featured on various news sites, providing readers with insightful analysis regarding the current state of gaming culture.
